Omalizumab as a Provoking Factor for Venous Thromboembolism

• Main Authors: Crhistian-Mario Oblitas (Author), Francisco Galeano-Valle (Author), Laura Vela-De La Cruz (Author), Jorge Del Toro-Cervera (Author), Pablo Demelo-Rodríguez (Author)
• Format: Book
• Published: AboutScience Srl, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain. Computed tomography pulmonary angiography showed bila...